Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

Alzheimers Dement. 2015 Sep;11(9):1121-2. doi: 10.1016/j.jalz.2015.02.002. Epub 2015 Apr 7.

¹ Innovative Medicine Initiative (IMI), Brussels, Belgium.
² Janssen Research & Development LLC, A division of Johnson & Johnson, Beerse, Belgium.
³ Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁴ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS) Maastricht University, Maastricht, The Netherlands.
⁵ Centre for Clinical Brain Sciences/Department of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
⁶ Head of Global Exploratory Development, UCB Pharma SPRL, Chemin du Foriest, Braine-l'Alleud, Belgium.
⁷ Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
⁸ Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany. Electronic address: martin.hofmann-apitius@scai.fraunhofer.de.
⁹ Department of Immunology, Innovative Medicines Initiative, Université Libre de Bruxelles, Brussels, Belgium.

No abstract available

Publication types